Peripheral inflammatory markers in Alzheimer’s disease: a systematic review and meta-analysis of 175 studies
The DOI matches its Crossref record; 85 of the 86 references it cites were found in a registry or an index.
Abstract
Objectives Increasing evidence suggests that inflammation is involved in Alzheimer's disease (AD) pathology. This study quantitatively summarised the data on peripheral inflammatory markers in patients with AD compared with healthy controls (HC). Methods Original reports containing measurements of peripheral inflammatory markers in AD patients and HC were included for meta-analysis. Standardised mean differences were calculated using a random effects model. Meta-regression and exploration of heterogeneity was performed using publication year, age, gender, Mini-Mental State Examination (MMSE) scores, plasma versus serum measurements and immunoassay type. Results A total of 175 studies were combined to review 51 analytes in 13 344 AD and 12 912 HC patients. Elevated peripheral interleukin (IL)-1β, IL-2, IL-6, IL-18, interferon-γ, homocysteine, high-sensitivity C reactive protein, C-X-C motif chemokine-10, epidermal growth factor, vascular cell adhesion molecule-1, tumour necrosis factor (TNF)-α converting enzyme, soluble TNF receptors 1 and 2, α1-antichymotrypsin and decreased IL-1 receptor antagonist and leptin were found in patients with AD compared with HC. IL-6 levels were inversely correlated with mean MMSE scores. Conclusions These findings suggest that AD is accompanied by a peripheral inflammatory response and that IL-6 may be a useful biological marker to correlate with the severity of cognitive impairment. Further studies are needed to determine the clinical utility o…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most notably, IL-6, IL-1β, TGF-β and TNF-α levels have been reported to be elevated in AD brain tissue [96,97,212,213,214]”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [213]
In the citing paper
“Many inflammatory mediators known to increase with aging (IL-1β, IL-18, sTNF-R1) are upregulated to an even greater extent in neurodegenerative conditions such as AD and Parkinson’s disease (PD) (100, 145–147).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [146]
In the citing paper
“inflammation also contributes to the pathogenesis of other chronic non-CVDs — such as anaemia, cancer, type 2 diabetes, dementia, osteoporosis, sarcopenia, chronic kidney disease, and depression”
From Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty (2018) · cites this paper as [139]
In the citing paper
“CVDs in old age often develop in the context of multimorbidity and frailty”
From Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty (2018) · cites this paper as [139]
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
(2014) · Medical Entomology and Zoology · Cited by 17,633
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00136 · Cited by 10,349
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480
Tumor necrosis factor signaling
Wajant, H., Pfizenmaier, K., & Scheurich, P. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401189 · Cited by 2,359
The Mini-Mental State Examination
Folstein, M. F. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790060110016 · Cited by 1,936
Carpenter, G., & Cohen, S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38983-5 · Cited by 1,622
A review on Alzheimer's disease pathophysiology and its management: an update
Kumar, A., Singh, A., & Ekavali (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2014.09.004 · Cited by 1,578
A Meta-Analysis of Cytokines in Alzheimer's Disease
Swardfager, W., Lanctôt, K., Rothenburg, L., Wong, A., Cappell, J., & Herrmann, N. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.012 · Cited by 1,108
Self-citationPlasma phospholipids identify antecedent memory impairment in older adults
Mapstone, M., Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., MacArthur, L. H., Hall, W. J., Fisher, S. G., Peterson, D. R., Haley, J. M., et al. (2014) · Nature Medicine · doi:10.1038/nm.3466 · Cited by 1,043
Metan: fixed- and random-effects meta-analysis
Harris, R. J., Deeks, J. J., Altman, D. G., Bradburn, M. J., Harbord, R. M., & Sterne, J. A. C. (2008) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0800800102 · Cited by 1,027
2014 Alzheimer's disease facts and figures
Alzheimer's Association (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.02.001 · Cited by 1,020
Inflammatory mediators in the elderly
Krabbe, K. S., Pedersen, M., & Bruunsgaard, H. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.01.009 · Cited by 928
Cook-Mills, J. M., Marchese, M. E., & Abdala-Valencia, H. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3522 · Cited by 594
Perry, V. H. (2004) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2004.01.004 · Cited by 560
Minagar, A., Shapshak, P., Fujimura, R., Ownby, R., Heyes, M., & Eisdorfer, C. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00207-1 · Cited by 537
Blood-brain barrier transport of cytokines: a mechanism for neuropathology
Banks, W. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053381684 · Cited by 534
Inflammation and Alzheimer’s disease
Lee, Y.-J., Han, S. B., Nam, S.-Y., Oh, K.-W., & Hong, J. T. (2010) · Archives of Pharmacal Research · doi:10.1007/s12272-010-1006-7 · Cited by 396
Cellular adhesion molecules and atherogenesis
Price, D. T., & Loscalzo, J. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00153-9 · Cited by 388
Working memory, long-term memory, and medial temporal lobe function
Jeneson, A., & Squire, L. R. (2012) · Learning & Memory · doi:10.1101/lm.024018.111 · Cited by 368
The Role of Peripheral Inflammatory Markers in Dementia and Alzheimer's Disease: A Meta-Analysis
Koyama, A., O'Brien, J., Weuve, J., Blacker, D., Metti, A. L., & Yaffe, K. (2013) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gls187 · Cited by 322
Neuroinflammation in Alzheimer’s disease
Zhang, F., & Jiang, L. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s75546 · Cited by 276
Metabonomics in pharmaceutical R & D
Lindon, J. C., Holmes, E., & Nicholson, J. K. (2007) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.05673.x · Cited by 262
The significance of neuroinflammation in understanding Alzheimer’s disease
Eikelenboom, P., Veerhuis, R., Scheper, W., Rozemuller, A. J. M., van Gool, W. A., & Hoozemans, J. J. M. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0575-6 · Cited by 262
Role of metabolism in neurodegenerative disorders
Procaccini, C., Santopaolo, M., Faicchia, D., Colamatteo, A., Formisano, L., de Candia, P., Galgani, M., De Rosa, V., & Matarese, G. (2016) · Metabolism · doi:10.1016/j.metabol.2016.05.018 · Cited by 258
Entry of Blood-Borne Cytokines into the Central Nervous System: Effects on Cognitive Processes
Banks, W. A., Farr, S. A., & Morley, J. E. (2002) · Neuroimmunomodulation · doi:10.1159/000071472 · Cited by 228
Obesity and dementia: Adipokines interact with the brain
Arnoldussen, I. A. C., Kiliaan, A. J., & Gustafson, D. R. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.03.002 · Cited by 224
Shi, J.-Q., Shen, W., Chen, J., Wang, B.-R., Zhong, L.-L., Zhu, Y.-W., Zhu, H.-Q., Zhang, Q.-Q., Zhang, Y.-D., & Xu, J. (2011) · Brain Research · doi:10.1016/j.brainres.2010.10.053 · Cited by 219
Cerebral pattern of pro- and anti-inflammatory cytokines in dementias
Tarkowski, E., Liljeroth, A.-M., Minthon, L., Tarkowski, A., Wallin, A., & Blennow, K. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00088-1 · Cited by 219
Ancuta, P., Wang, J., & Gabuzda, D. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0206125 · Cited by 206
Treatment for Rheumatoid Arthritis and Risk of Alzheimer’s Disease: A Nested Case-Control Analysis
Chou, R. C., Kane, M., Ghimire, S., Gautam, S., & Gui, J. (2016) · CNS Drugs · doi:10.1007/s40263-016-0374-z · Cited by 194
Review on EGFR Inhibitors: Critical Updates
Singh, D., Kumar Attri, B., Kaur Gill, R., & Bariwal, J. (2016) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557516666160321114917 · Cited by 183
Sun, Y.-X., Minthon, L., Wallmark, A., Warkentin, S., Blennow, K., & Janciauskiene, S. (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000071001 · Cited by 180
CXCL10‐induced cell death in neurons: role of calcium dysregulation
Sui, Y., Stehno‐Bittel, L., Li, S., Loganathan, R., Dhillon, N. K., Pinson, D., Nath, A., Kolson, D., Narayan, O., & Buch, S. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04631.x · Cited by 175
Kálmán, J., Juhász, A., Laird, G., Dickens, P., Járdánházy, T., Rimanóczy, A., Boncz, I., Parry-Jones, W. L. I., & Janka, Z. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1997.tb00275.x · Cited by 167
Cytokines and the immune response
Van der Meide, P. H., & Schellekens, H. (1996) · Biotherapy · doi:10.1007/bf01877210 · Cited by 166
Bao, Y., & Cao, X. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.04.001 · Cited by 166
Dá Mesquita, S., Ferreira, A. C., Sousa, J. C., Correia-Neves, M., Sousa, N., & Marques, F. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.014 · Cited by 166
Inflammatory Proteins in Plasma Are Associated with Severity of Alzheimer’s Disease
Leung, R., Proitsi, P., Simmons, A., Lunnon, K., Güntert, A., Kronenberg, D., Pritchard, M., Tsolaki, M., Mecocci, P., Kloszewska, I., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064971 · Cited by 160
Systemic immune aberrations in Alzheimer's disease patients
Bonotis, K. S., Krikki, E., Holeva, V., Aggouridaki, C., Costa, V., & Balogiannis, S. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.10.020 · Cited by 147
Interleukin‐1β: a bridge between inflammation and excitotoxicity?
Fogal, B., & Hewett, S. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05315.x · Cited by 145
Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease
Teixeira, A. L., Diniz, B. S., Campos, A. C., de Miranda, A. S., Rocha, N. P., Talib, L. L., Gattaz, W. F., & Forlenza, O. V. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8201-2 · Cited by 143
Buchhave, P., Zetterberg, H., Blennow, K., Minthon, L., Janciauskiene, S. M., & Hansson, O. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.10.012 · Cited by 140
Blood-based biomarkers of microvascular pathology in Alzheimer’s disease
Ewers, M., Mielke, M. M., & Hampel, H. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2009.09.005 · Cited by 122
Study of interleukin-6 production in Alzheimer's disease.
Cojocaru, I. M., Cojocaru, M., Miu, G., & Sapira, V. (2011) · PubMed · Cited by 114
Hall, J. R., Wiechmann, A. R., Johnson, L. A., Edwards, M., Barber, R. C., Winter, A. S., Singh, M., & O’Bryant, S. E. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122359 · Cited by 112
Ferrer, I., Alcántara, S., Ballabriga, J., Olivé, M., Blanco, R., Rivera, R., Carmona, M., Berruezo, M., Pitarch, S., & Planas, A. M. (1996) · Progress in Neurobiology · doi:10.1016/0301-0082(96)00009-3 · Cited by 107
Permeability of the Blood-Brain Barrier to Soluble Cytokine Receptors
Banks, W. A., Plotkin, S. R., & Kastin, A. J. (1995) · Neuroimmunomodulation · doi:10.1159/000096887 · Cited by 105
Obesity as a risk factor for Alzheimer’s disease: the role of adipocytokines
Letra, L., Santana, I. J., & Seiça, R. M. F. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9501-z · Cited by 104
Altered Serum Levels of Adipokines and Insulin in Probable Alzheimer's Disease
Khemka, V. K., Bagchi, D., Bandyopadhyay, K., Bir, A., Chattopadhyay, M., Biswas, A., Basu, D., & Chakrabarti, S. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140006 · Cited by 101
Higher Serum sTNFR1 Level Predicts Conversion from Mild Cognitive Impairment to Alzheimer's Disease
Diniz, B. S., Teixeira, A. L., Ojopi, E. B., Talib, L. L., Mendonça, V. A., Gattaz, W. F., & Forlenza, O. V. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100921 · Cited by 101
Cytokines in Alzheimer's Disease and Vascular Dementia
Angelopoulos, P., Agouridaki, H., Vaiopoulos, H., Siskou, E., Doutsou, K., Costa, V., & Baloyiannis, S. I. (2008) · International Journal of Neuroscience · doi:10.1080/00207450701392068 · Cited by 100
Chemokines and Alzheimer's disease
Streit, W., Conde, J. R., & Harrison, J. K. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00290-1 · Cited by 98
Ancuța, P., Moses, A. V., & Gabuzda, D. H. (2004) · Immunobiology · doi:10.1016/j.imbio.2004.04.001 · Cited by 96
Sundelöf, J., Kilander, L., Helmersson, J., Larsson, A., Rönnemaa, E., Degerman-Gunnarsson, M., Basun, H., Lannfelt, L., & Basu, S. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1126 · Cited by 94
Mechanisms of Glucocorticoids in the Control of Neuroinflammation
Schweingruber, N., Reichardt, S. D., Lühder, F., & Reichardt, H. M. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02161.x · Cited by 89
Nelson, T. E., & Gruol, D. L. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.07.009 · Cited by 88
Variability of gene expression profiles in human blood and lymphoblastoid cell lines
Min, J. L., Barrett, A., Watts, T., Pettersson, F. H., Lockstone, H. E., Lindgren, C. M., Taylor, J. M., Allen, M., Zondervan, K. T., & McCarthy, M. I. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-96 · Cited by 85
Huang, C.-W., Tsai, M.-H., Chen, N.-C., Chen, W.-H., Lu, Y.-T., Lui, C.-C., Chang, Y.-T., Chang, W.-N., Chang, A. Y. W., & Chang, C.-C. (2015) · Thrombosis and Haemostasis · doi:10.1160/th14-11-0938 · Cited by 82
Neuroprotective effects of leptin in the context of obesity and metabolic disorders
Davis, C., Mudd, J., & Hawkins, M. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.04.012 · Cited by 81
Targeting neuroinflammation in Alzheimer’s disease: evidence for NSAIDs and novel therapeutics
Deardorff, W. J., & Grossberg, G. T. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1200972 · Cited by 81
Chemokines in CSF of Alzheimer's disease patients
Corrêa, J. D., Starling, D., Teixeira, A. L., Caramelli, P., & Silva, T. A. (2011) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2011000400009 · Cited by 79
Homocysteine Induced Cerebrovascular Dysfunction: A Link to Alzheimer’s Disease Etiology
Kamat, P. K., Vacek, J. C., Kalani, A., & Tyagi, N. (2015) · The Open Neurology Journal · doi:10.2174/1874205x01509010009 · Cited by 78
Uslu, S., Akarkarasu, Z. E., Özbabalık, D., Özkan, S., Çolak, Ö., Demirkan, E. S., Özkıriş, A., Demirüstü, C., & Alataş, Ö. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0750-0 · Cited by 75
Engineering Theranostic Nanovehicles Capable of Targeting Cerebrovascular Amyloid Deposits
Agyare, E. K., Jaruszewski, K. M., Curran, G. L., Rosenberg, J. T., Grant, S. C., Lowe, V. J., Ramakrishnan, S., Paravastu, A. K., Poduslo, J. F., & Kandimalla, K. K. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.010 · Cited by 71
Hamm, H. E., Deretic, D., Hofmann, K. P., Schleicher, A., & Kohl, B. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61039-7 · Cited by 69
Astrocytic Alterations in Interleukin-6/Soluble Interleukin-6 Receptor α Double-Transgenic Mice
Brunello, A., Weissenberger, J., Каппелер, А., Vallan, C., Peters, M., Rose‐John, S., & Weis, J. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64787-6 · Cited by 67
Johnston, J., Hu, W., Fardo, D., Greco, S., Perry, G., Montine, T., Trojanowski, J., Shaw, L., Ashford, J., & Tezapsidis, N. (2014) · Current Alzheimer Research · doi:10.2174/1567205010666131212114156 · Cited by 64
Chronic CXCL10 alters neuronal properties in rat hippocampal culture
Cho, J., Nelson, T. E., Bajova, H., & Gruol, D. L. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.12.007 · Cited by 60
Delaby, C., Gabelle, A., Blum, D., Schraen-Maschke, S., Moulinier, A., Boulanghien, J., Séverac, D., Buée, L., Rème, T., & Lehmann, S. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00181 · Cited by 57
Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease
Lim, N. S., Swanson, C. R., Cherng, H., Unger, T. L., Xie, S. X., Weintraub, D., Marek, K., Stern, M. B., Siderowf, A., PARS Investigators, et al. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.299 · Cited by 57
Epidermal growth factor: the receptor and its function.
Todderud, G., & Carpenter, G. F. (1989) · PubMed · Cited by 56
A pilot study on the use of interferon beta-1a in early Alzheimer’s disease subjects
Grimaldi, L. M., Zappalà, G., Iemolo, F., Castellano, A., Ruggieri, S., Bruno, G., & Paolillo, A. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-30 · Cited by 54
Plasma beta amyloid and cytokine profile in women with Alzheimer's disease.
Baranowska-Bik, A., Bik, W., Wolińska‐Witort, E., Martyńska, L., Chmielowska, M., Barcikowska, M., & Baranowska, B. (2008) · PubMed · Cited by 50
Induction of β-amyloid precursor protein isoform mRNAs by bFGF in astrocytes
Gray, C. W., & Patel, A. J. (1993) · Neuroreport · doi:10.1097/00001756-199306000-00054 · Cited by 44
Lai, W., Wu, J., Zou, X., Xie, J., Zhang, L., Zhao, X., Zhao, M., Wang, Q., & Ji, J. (2012) · Journal of Proteome Research · doi:10.1021/pr300895r · Cited by 36
Teixeira, A. L., Reis, H. J., Coelho, F. M., Carneiro, D. S., Teixeira, M. M., Vieira, L. B., Mukhamedyarov, M. A., Zefirov, A. L., Janka, Z., & Palotás, A. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.07.019 · Cited by 34
Noble, J. E., Wang, L., Cerasoli, E., Knight, A. E., Porter, R. A., Gray, E., Howe, C., Hannes, E., Corbisier, P., Wang, J., et al. (2008) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2008.182 · Cited by 31
Systemische Veränderungen des Immunsystems bei Patienten mit Alzheimer-Demenz
Leblhuber, F., Walli, J., Tilz, G. P., Wächter, H., & Fuchs, D. (2008) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-2007-1024069 · Cited by 25
Wieczorek, L., Brown, B. K., Macedo, C. D., Wesberry, M., Ngauy, V., Borges, A. R., Michael, N. L., Marovich, M., Montefiori, D. C., & Polonis, V. R. (2013) · Virology · doi:10.1016/j.virol.2013.09.014 · Cited by 22
Laske, C., Schmohl, M., Leyhe, T., Stransky, E., Maetzler, W., Berg, D., Fallgatter, A. J., Joos, T., & Dietzsch, J. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-121558 · Cited by 22
Research works printed but not linked: 1
- Leblhuber, 1998, [Systemic changes of the immune system in patients with Alzheimer’s dementia], Dtsch Med Wochenschr, 123, 787
Cited by
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
Ferrucci, L., & Fabbri, E. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0064-2 · Cited by 3,690
Neuroinflammation in Alzheimer disease
Heneka, M. T., van der Flier, W. M., Jessen, F., Hoozemanns, J., Thal, D. R., Boche, D., Brosseron, F., Teunissen, C., Zetterberg, H., Jacobs, A. H., et al. (2025) · Nature Reviews Immunology · doi:10.1038/s41577-024-01104-7 · Cited by 638
“Studies on ‘classical’ inflammation markers, like C-reactive protein (CRP) or pro-inflammatory cytokines, are large in number but have shown limited consistency in meta-analyses 31,32 .”
Current state of Alzheimer’s fluid biomarkers
Molinuevo, J. L., Ayton, S., Batrla, R., Bednar, M. M., Bittner, T., Cummings, J., Fagan, A. M., Hampel, H., Mielke, M. M., Mikulskis, A., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1932-x · Cited by 518
Effect of High-Fat Diets on Oxidative Stress, Cellular Inflammatory Response and Cognitive Function
Tan, B. L., & Norhaizan, M. E. (2019) · Nutrients · doi:10.3390/nu11112579 · Cited by 511
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
Metadata
- Authors
- Lai, K. S. P., Liu, C. S., Rau, A., Lanctôt, K. L., Köhler, C. A., Pakosh, M., Carvalho, A. F., & Herrmann, N.
- Affiliations
- Sunnybrook Health Science Centre (CA)
- Universidade Federal do Ceará (BR)
- University Health Network (CA)
- Corresponding author
- Herrmann, Nathan
- ORCID
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2017-08-09
- Volume
- 88
- Issue
- 10
- Pages
- 876-882
- ISSN
- 0022-3050 (ISSN-L)
- 1468-330X
- OpenAlex
- W2744015013
- Cited by
- 433
- References
- 86
- Citations by year
- 2026: 26 · 2025: 36 · 2024: 56 · 2023: 45 · 2022: 66 · 2021: 48 · 2020: 65 · 2019: 51 · 2018: 35 · 2017: 5
- FWCI
- 6.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neurology Neurosurgery & Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, peripheral inflammatory markers, neuroinflammation, interleukin-6, C-reactive protein, homocysteine, TNF-α, soluble TNF receptors, interleukin-1, cognitive impairment, biomarkers
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Humans, Inflammation, Biomarkers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.